Cargando…
Early and Complete Response of Bone Metastases, Documented by FDG-PET/CT Scan, in a Patient With NSCLC
In this case report we describe the case of a patient with multiple bone metastases of NSCLC, adenocarcinoma with exon 21 point-mutation of EGFR, treated with gefitinib. After only 3 months, FDG-PET/CT scan showed a complete response of bone metastases and right hylar adenopathy. Implications for ne...
Autores principales: | Rossi, David, Giordani, Paolo, Alessandroni, Paolo, Catalano, Vincenzo, Casadei, Virginia, Baldelli, Anna Maria, Fedeli, Stefano Luzi, Graziano, Francesco, Fiorentini, Giammaria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649835/ https://www.ncbi.nlm.nih.gov/pubmed/29147277 http://dx.doi.org/10.4021/wjon441w |
Ejemplares similares
-
“Short Course” of Nonpegylated Liposomal Doxorubicin Plus Paclitaxel and Trastuzumb as Primary Systemic Therapy for Operable and Locally-Advanced Breast Cancer: A Phase II Study (PacLiDox 07)
por: Rossi, D., et al.
Publicado: (2011) -
Comparison between FDG-PET/CT and bone scan in bone metastasis from NSCLC
por: Tamura, Tomohiro, et al.
Publicado: (2014) -
Comparison of CE-FDG-PET/CT with CE-FDG-PET/MR in the evaluation of osseous metastases in breast cancer patients
por: Catalano, O A, et al.
Publicado: (2015) -
Second-line chemotherapy for patients with advanced gastric cancer: who may benefit?
por: Catalano, V, et al.
Publicado: (2008) -
Hematogenous muscular metastasis of NSCLC in FDG-PET/CT
por: Satoh, Hiroaki, et al.
Publicado: (2015)